Blood News and Research

RSS

BAK/MCL1 complex in tumor cells can predict the sensitivity of chemotherapy drugs in ovarian cancer

A research team led by Prof. DAI Haiming from the Hefei Institutes of Physical Science (HFIPS) of the Chinese Academy of Sciences (CAS) recently announced the constitutive BAK/MCL1 complexes could predict chemotherapy drugs sensitivity of ovarian cancer. The result has been published on Cell death & disease.

16 Sep 2021

Research reveals vital role of protein-coding gene in tumor development and immune therapy response

Researchers from the Case Comprehensive Cancer Center uncovered the potentially important role of the protein-coding gene, MYO10, in tumor development and immune therapy response. Their findings were published today in Science Advances.

16 Sep 2021

NYU Langone completes study designs for NIH research initiative on long-term impact of COVID-19

NYU Langone Health, as the Clinical Science Core for the National Institutes of Health's RECOVER initiative, has, since the announcement of the beginning of its operations on June 10, convened more than 100 researchers from 35 institutions as well as patients to finalize the main study protocols for the adult, pediatric, and autopsy patient groups (cohorts).

15 Sep 2021

Epigenetic aging could be a promising biomarker for measuring cardiovascular disease risk

Epigenetic aging — derived from the molecular mechanisms governing gene regulation — could serve as a promising biomarker for measuring long-term cardiovascular health and disease risk, according to a Northwestern Medicine study published in the journal Circulation Research.

15 Sep 2021

Study discovers biological mechanism linking long-term arsenic exposure to cancer, diabetes

A University of Arizona Health Sciences study has identified the biological mechanism linking long-term arsenic exposure to diseases such as cancer and Type 2 diabetes.

15 Sep 2021

Link identified between early lower respiratory tract infections and development of OSA in children

Several birth cohorts have defined the pivotal role of early lower respiratory tract infections (LRTI) in the inception of pediatric respiratory conditions.

15 Sep 2021

NIH awards funding to build a national study population of volunteers on long-term effects of COVID-19

The National Institutes of Health awarded nearly $470 million to build a national study population of diverse research volunteers and support large-scale studies on the long-term effects of COVID-19.

15 Sep 2021

Researchers develop a new tool to help provide early warning of rare and unknown viruses

Researchers at McMaster University have developed a sophisticated new tool that could help provide early warning of rare and unknown viruses in the environment and identify potentially deadly bacterial pathogens which cause sepsis, among other uses.

15 Sep 2021

Analysis of the immune landscape in mild-to-moderate COVID-19

A new study includes an analysis of plasma cytokine levels, peripheral blood immune cell composition, and SARS-CoV-2 specific Igs in COVID-19.

15 Sep 2021

Flavonoids can potentially help prevent COVID-19-induced diarrhea, study finds

A recent study published in Tropical Biomedicine determines whether flavonoids can help prevent diarrhea caused by SARS-CoV-2 infection.

15 Sep 2021

The Indian second wave: SARS-CoV-2 infection-induced immunity could be ineffective in protecting population

Researchers decided to investigate how effective immunity gained from previous SARS-CoV-2 infection protects a wider community from disease.

15 Sep 2021

AI test provides Covid-19 screening results quicker than lateral flow tests

An Artificial Intelligence (AI) test performed by the bedside in 10 minutes quickly and safely triages patients coming to hospital for Covid-19, a University of Oxford-led study has shown.

15 Sep 2021

Deep profiling of SARS-CoV-2 immune response amongst the mildly symptomatic

In a research paper recently uploaded to the medRxiv* preprint server by Capelle et al. (September 2nd, 2021), the immune response of mild and hospitalized COVID-19 patients is compared, finding that early T-cell response is a vital indicator of SARS-CoV-2 disease severity.

15 Sep 2021

Blood clot risks are high following SARS-CoV-2 infection, not vaccination

Researchers from the University of Oxford have today announced the results of a study into thrombocytopenia (a condition with low platelet counts) and thromboembolic events (blood clots) following vaccination for Covid-19, some of the same events which have led to restricted use of the Oxford-AstraZeneca vaccine in a number of countries.

15 Sep 2021

SARS-CoV-2 can cause sustained biochemical dysregulation that results in long-COVID

This state has come to be known as long-COVID, and in a paper recently uploaded to the preprint server medRxiv* by Simjanoska et al. (September 7th, 2021) the biochemical parameters of long-COVID patients with prior mild, moderate, or severe COVID-19 that resulted in hospitalization are tracked in detail, finding a characteristically dysregulated immune and inflammatory response in the most seriously ill.

15 Sep 2021

Blood News and Research

BAK/MCL1 complex in tumor cells can predict the sensitivity of chemotherapy drugs in ovarian cancer

Research reveals vital role of protein-coding gene in tumor development and immune therapy response

NYU Langone completes study designs for NIH research initiative on long-term impact of COVID-19

Epigenetic aging could be a promising biomarker for measuring cardiovascular disease risk

Study discovers biological mechanism linking long-term arsenic exposure to cancer, diabetes

Link identified between early lower respiratory tract infections and development of OSA in children

NIH awards funding to build a national study population of volunteers on long-term effects of COVID-19

Researchers develop a new tool to help provide early warning of rare and unknown viruses

Analysis of the immune landscape in mild-to-moderate COVID-19

Flavonoids can potentially help prevent COVID-19-induced diarrhea, study finds

The Indian second wave: SARS-CoV-2 infection-induced immunity could be ineffective in protecting population

AI test provides Covid-19 screening results quicker than lateral flow tests

Deep profiling of SARS-CoV-2 immune response amongst the mildly symptomatic

Blood clot risks are high following SARS-CoV-2 infection, not vaccination

SARS-CoV-2 can cause sustained biochemical dysregulation that results in long-COVID

Quantification of salivary IgG and IgA against SARS-CoV-2

Blocking a specific immune cell could reverse antibiotic-induced breast cancer growth

UNSW Sydney scientists discover how tiny anchors help the cells to stay in place

Liver may play a key role in the onset or progression of Alzheimer's disease

Pregnancy complications with COVID-19

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News